L
Lairui Medical
Developer and manufacturer of neurointerventional medical devices designed to provide solutions for ischemic and hemorrhagic stroke
About Lairui Medical
Established in 2019, Lairui Medical operates as a manufacturer of medical devices geared towards advancing precision healthcare. The company's core business involves the production of minimally invasive surgical instruments, diagnostic equipment, and the provision of customized medical technology services. These offerings are designed to provide healthcare professionals with tools that aim to improve clinical accuracy and enhance patient safety.
The company serves the healthcare market, providing its products and services to medical facilities and practitioners. The business model is centered on the sale of these physical devices and related technology services. While specific details on how it generates revenue are not publicly detailed, it is based on the manufacturing and sales of its medical device portfolio.
A notable event in the company's history is its acquisition on March 11, 2025. Lairui Medical has also been active in intellectual property development, with recent patent activity including a filing for an engagement assembly, core assembly, system, and method for delivering an implant.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 20.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Neurology, Hard Tech, DT and LS, science-based, stroke
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2022 | $40M | $160M | Xunshang Venture Capital · Zhemin Investment | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- XCXunshang Venture Capital
- ZIZhemin Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lairui Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lairui Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.